Abstract:Ye Zhou, Yangliang Yang, Liang Yi, Mengzhi Pan, Weiqing Tang, Hongwei Duan Department of Anesthesiology, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, People's Republic of China Correspondence: Hongwei Duan, Email Background: Sepsis is recognized as a multiorgan and systemic damage caused by dysregulated host response to infection. Its acute systemic inflammatory response highly resembles that of lipopolysaccharide (LPS)-induced endotoxemia. Propofol and dexmedetomidine are two commonly used sedatives for mechanical ventilation in critically ill patients and have been reported to alleviate cognitive impairment in many diseases. In this study, we aimed to explore and compare the effects of propofol and dexmedetomidine on the encephalopathy induced by endotoxemia and to investigate whether ferroptosis is involved, finally providing experimental evidence for multi-drug combination in septic sedation. Methods: A total of 218 C57BL/6J male mice (20– 25 g, 6– 8 weeks) were used. Morris water maze (MWM) tests were performed to evaluate whether propofol and dexmedetomidine attenuated LPS-induced cognitive deficits. Brain injury was evaluated using Nissl and Fluoro-Jade C (FJC) staining. Neuroinflammation was assessed by dihydroethidium (DHE) and DCFH-DA staining and by measuring the levels of three cytokines. The number of Iba1 + and GFAP + cells was used to detect the activation of microglia and astrocytes. To explore the involvement of ferroptosis, the levels of ptgs2 and chac1 ; the content of iron, malondialdehyde (MDA), and glutathione (GSH); and the expression of ferroptosis-related proteins were investigated. Conclusion: The single use of propofol and dexmedetomidine mitigated LPS-induced cognitive impairment, while the combination showed poor performance. In alleviating endotoxemic neural loss and degeneration, the united sedative group exhibited the most potent capability. Both propofol and dexmedetomidine inhibited neuroinflammation, while propofol's effect was slightly weaker. All sedative groups reduced the neural apoptosis, inhibited the activation of microglia and astrocytes, and relieved neurologic ferroptosis. The combined group was most prominent in combating genetic and biochemical alterations of ferroptosis. Fpn1 may be at the core of endotoxemia-related ferroptosis activation. Keywords: propofol, dexmedetomidine, endotoxemia, encephalopathy, ferroptosis Over 20 million patients suffer from sepsis worldwide each year, standing as a prominent contributor to fatalities within the Intensive Care Unit (ICU) setting. 1,2 During the progression of sepsis, intense inflammatory storm provokes the overactivation of immune system, ultimately causing immunosuppression. 3,4 Excessive cytokines can penetrate the blood–brain barrier and aggravate neuroinflammation and secondary neurodegeneration. 5 Endotoxemia triggered by LPS administration can closely mimic this acute inflammatory response of sepsis. 6 Ferroptosis is a form of non-apoptotic cell debris, featured by the iron-dependent peroxidation of membrane lipids. 7 Overaccumulation of iron catalyzes the production of reactive oxygen species (ROS) through Fenton reaction, facilitating the hydroxylation of unsaturated fatty acids (UFA). This process compromises the structure and function of the cell membrane, and activates ferroptosis-related lipid peroxidation. 8,9 As research advances, the intricate relationship between ferroptosis and endotoxemia has been progressively unraveled and substantiated. The reinforcement of ferroptosis by ferroportin (Fpn1) knockdown enhances the atrial fibrillation (AF) vulnerability in endotoxemia rat model. 10 Meanwhile, resveratrol has been confirmed to protect against LPS-mediated myocardial injury through elevating miR-149, which inhibits ferroptosis. 11 Propofol is a short-acting intravenous anesthetic that is widely used for swift induction, stable maintenance, and prompt recovery. 12 Dexmedetomidine, a specific α2-adrenoceptor agonist, provides efficient sedation, with a slight analgesic effect. 13 The Society of Critical Care Medicine (SCCM) recommends the use of propofol and dexmedetomidine during endotracheal intubation to achieve a low level of sedation. 14 Compared with propofol, dexmedetomidine presents distinct benefits, such as anti-inflammatory properties, promotion of biomimetic sleep, and diminishment of acute brain dysfunction risk. However, under light sedation, dexmedetomidine and propofol showed no differential impact on survival outcomes or on the duration of ICU stay for mechanically ventilated adult patients with sepsis. 2 Although dexmedetomidine red -Abstract Truncated-

Dexmedetomidine Ameliorates Muscle Wasting And Attenuates The Alteration Of Hypothalamic Neuropeptides And Inflammation In Endotoxemic Rats

Insulin Ameliorating Endotoxaemia-Induced Muscle Wasting is Associated with the Alteration of Hypothalamic Neuropeptides and Inflammation in Rats.

Dexmedetomidine Controls Systemic Cytokine Levels Through the Cholinergic Anti-inflammatory Pathway

Hypothalamic activation is essential for endotoxemia-induced acute muscle wasting

Dexmedetomidine ameliorates endotoxin-induced acute lung injury in vivo and in vitro by preserving mitochondrial dynamic equilibrium through the HIF-1a/HO-1 signaling pathway

Exogenous Melatonin Alleviates Skeletal Muscle Wasting by Regulating Hypothalamic Neuropeptides Expression in Endotoxemia Rats

Mild Hypothermia Ameliorates Muscle Wasting in Septic Rats Associated with Hypothalamic AMPK-induced Autophagy and Neuropeptides.

Effect of Dexmedetomidine on Mitochondrial Dynamics in Mice with Endotoxin-Induced Acute Lung Injury

Dexmedetomidine attenuates pyohemia-associated delirium in mice through the cholinergic anti-inflammatory pathway

Dexmedetomidine Exerts an Anti-inflammatory Effect via α2 Adrenoceptors to Prevent Lipopolysaccharide-induced Cognitive Decline in Mice.

Dexmedetomidine Attenuates Lipopolysaccharide-Induced Inflammation Through Macrophageal IL-10 Expression Following Α7 Nachr Activation

Different cellular responses of dexmedetomidine at infected site and peripheral blood of emdotoxemic BALB/c mice.

Dexmedetomidine Attenuates Inflammatory Reaction in the Lung Tissues of Septic Mice by Activating Cholinergic Anti-Inflammatory Pathway

Dexmedetomidine Attenuates Lipopolysaccharide-Induced Liver Oxidative Stress and Cell Apoptosis in Rats by Increasing GSK-3β/MKP-1/Nrf2 Pathway Activity Via the Α2 Adrenergic Receptor.

Dexmedetomidine Ameliorated Cognitive Dysfunction Induced by Intestinal Ischemia Reperfusion in Mice with Possible Relation to the Anti-inflammatory Effect Through the Locus Coeruleus Norepinephrine System

Propofol and Dexmedetomidine Ameliorate Endotoxemia-Associated Encephalopathy via Inhibiting Ferroptosis

Dexmedetomidine Attenuates Myocardial Ischemia-Reperfusion Injury in Hyperlipidemic Rats by Inhibiting Inflammation, Oxidative Stress and NF-B

Dexmedetomidine Ameliorates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by Targeting SCD1 in Obesity Mice.

Dexmedetomidine Attenuates Pancreatic Injury and Inflammatory Response in Mice with Pancreatitis by Possible Reduction of NLRP3 Activation and Up-Regulation of NET Expression.

Dexmedetomidine Mitigated NLRP3-Mediated Neuroinflammation Via the Ubiquitin-Autophagy Pathway to Improve Perioperative Neurocognitive Disorder in Mice

Dexmedetomidine Exerts an Anti-inflammatory Effect Via Α2 Adrenoceptors to Prevent Lipopolysaccharide-induced Cognitive Decline in Mice